Blogs | Multibagger Shares

March 16, 2026

Titan Biotech Header with Subtitle Horizontal Bar Chart Shows Yearly Values from Fy20 to Fy25 Fy20 28 Fy21 26 Fy22 22 Fy23 18 Fy24 14 Fy25 11 green

Titan Biotech: From ₹8 to ₹400 — The 50x Multibagger Story | Value Investing #Shorts

📅 Published March 16, 2026 (Monday) https://multibaggershares.com/wp-content/uploads/2026/03/titan_biotech_50x_english_short.mp4 Titan Biotech (BSE: 524717) turned ₹8 into ₹400 — a stunning 50x multibagger return! Learn the 3 key factors […]

March 16, 2026

Hero Section Article Title About Rupee Until ₹93$ Subtitle in Italics Includes a Horizontal Bar Chart Showing Fy20fy25 Values with the Final Bar Highlighted in Green 11 in Fy25

Rupee at ₹93/$ — Why This Is a Golden Opportunity for Pharma & Biotech Investors

The Indian Rupee has depreciated to ~93 per US Dollar. While headlines scream doom, smart investors see this as a powerful tailwind for India's $30B+ pharma export engine. India is the Pharmacy of the World — and a weaker rupee makes it even more competitive. Here's why pharma & biotech stocks are the biggest beneficiaries.

March 16, 2026

Hero Header with the Title economic Moats and Green Subtitle on a Dark Blue Background a Two by two Color Block Grid Labeled Trader gray Compunder green Drift light Gray Speculator orange Footer Credit Text

Economic Moats: How to Find Companies That Competitors Simply Cannot Destroy

📅 Published March 16, 2026 (Monday) Table of Contents Toggle What Is an Economic Moat? The Five Types of Economic Moats 1. Cost Advantage Moat 2. […]

March 15, 2026

Hero Title How Titan Biotech Turned ₹1 Lakh with a Subtitle About Audited Fy25 Numbers and Shares Growth illustrative Article Header

How Titan Biotech Turned ₹1 Lakh into ₹50 Lakh — A Value Investing Case Study

Learn how Titan Biotech (BSE:524717) turned ₹1 Lakh into ₹50 Lakh — a real 50x multibagger case study with a 7-step value investing framework by Manish Goel, SEBI Registered Investment Advisor.